The desglycinyl metabolite of remacemide hydrochloride is neuroprotective in cultured rat cortical neurons

Journal of Neurochemistry

Volumn 66, Issue 3, 1996, Pages 989-995

  Black, Marsha A ^a   Tremblay, Roger ^a   Mealing, Geoffrey A R ^a   Durkin, Jon P ^a   Whitfield, James F ^a   Morley, Paul ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Calcium; Cortical; Glutamate; Neurons; Neuroprotection; Neurotoxicity; NMDA; Protein kinase C; Remacemide

Indexed keywords

1 METHYL 1,2 DIPHENYLETHYLAMINE; ANTICONVULSIVE AGENT; CALCIUM ION; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; REMACEMIDE;

ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030064792     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66030989.x     Document Type: Article

References (34)

1. Bannan P. E., Graham D. I , Lees K. R., and McCulloch J. (1994) Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat. Brain Res. 664, 271-275.
2. Black M. A., Tremblay R., Mealing G., Ray R., Durkin J. P., Whitfield J. F., Blosser J., and Morley P. (1995) N-Methyl-D-aspartate- or glutamate-mediated toxicity in cultured rat cortical neurons is antagonized by FPL 15896AR. J. Neurochem. 65, 2170-2177.
3. Cardell M. and Weiloch T. (1993) Time course of the translocation and inhibition of protein kinase C during complete cerebral ischemia in the rat J. Neurochem. 61, 1308-1314.
4. Chakravarthy B. R., Bussey A., Whitfield J. F., Sikorska M., Williams R. E., and Durkin J. P. (1991) The direct measurement of protein kinase C (PKC) activity in isolated membranes using a selective peptide substrate. Anal. Biochem. 196, 144-150.
5. Chakravarthy B., Whitfield J. F., and Durkin J. P. (1994) Inactive membrane protein kinase Cs - A possible target for receptor signalling. Biochem. J. 304, 809-816.
6. Chen H.-S. V., Pellegrini J. W., Aggarwal S. K., Lei S. Z., Warach S., Jensen F. E., and Lipton S. A. (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated toxicity. J. Neurosci. 12, 4427-4435.
7. Choi D. W., Maulucci-Gedde M. A., and Kriegstein A. R. (1987) Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368.
8. Cox J. A., Lysko P. G., and Henneberry R. C. (1989) Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: role of the voltage-dependent magnesium block. Brain Res. 499, 267-272.
9. Crumrine R. C., Dubyak G., and LaManna J. C. (1990) Decreased protein kinase C activity during cerebral ischemia and after reperfusion in the adult rat. J. Neurochem. 55, 2001-2007.
10. Dichter M. A. (1973) Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation. Brain Res. 149, 279-293.
11. Domańska-Janik K. and Zalewska T. (1992) Effect of brain ischemia on protein kinase C. J. Neurochem. 58, 1432-1439.
12. Dubinsky J. M. and Rothman S. M. (1991) Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury. J. Neurosci. 11, 2545-2551.
13. Durkin J. P., Tremblay R., Buchan A. M., Blosser J., Chakravarthy B., Mealing G., Morley P., and Song D. (1996) An early loss in membrane protein kinase C activity precedes the excitatory amino acid-induced death of primary cortical neurons. J. Neurochem. 66, 951-962.
14. Giffard R. G., Weiss J. H., Swanson R. A., and Choi D. W. (1993) Secobarbital attenuates excitotoxicity but potentiates oxygen-glucose deprivation neuronal injury in cortical cell culture. J. Cereb. Blood Flow Metab. 13, 803-810.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
16. Harris E., Stagnitto M., Garske G., Cregan E., Ray R., Julien R., Wilson T., Machulskis G., Bialobok P., White J., and Palmer G. (1992) Neuroprotection in animals by remacemide, a prodrug for noncompetitive NMDA antagonism with a high therapeutic index, in Mechanisms for Neuromodulation and Neuroprotection (Kamenka J. M. and Domino E. F., eds), pp. 643-653. NPP Books, Ann Arbor, Michigan.
17. Hartley D M. and Choi D. W. (1989) Delayed rescue of N-methyl-D-aspartate receptor mediated neuronal injury in cortical culture. J. Pharmacol. Exp. Ther. 250, 752-758.
18. Iversen L. L. (1994) MK-801 (dizocilpine maleate) - NMDA receptor antagonist. Neurotransmissions 10, 1-4.
19. Kemp J. A., Foster A. C., and Wong E. H. F. (1987) Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci. 10, 294-298.
20. Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622.
21. Lysko P. G., Cox J A., Vigano M. A., and Henneberry R. C. (1989) Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization. Brain Res. 499, 258-266.
22. 2+ homeostasis in glutamate-induced neuronal death, in Neurotoxicity of Excitatory Amino Acids (Guidotti A., ed), pp. 63-78. Raven Press, New York
23. Michaels R. L. and Rothman S. M. (1990) Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J. Neurosci. 10, 283-292.
24. Moudy A. M., Yamada K. A., and Rothman S. M. (1994) Rapid desensitization determines the pharmacology of glutamate neurotoxicity. Neuropharmacology 33, 953-962
25. Murphy S. N., Thayer S. A., and Miller R. J (1987) The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro. J. Neurosci. 7, 4145-4158.
26. Novelli A., Reilly J. A., Lysko P. G., and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
27. Olney J. W., Labruyere J., and Price M. T. (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
28. Ordy J. M., Volpe B , Murray R , Thomas G., Bialobok P., Wengenack T. M., and Dunlap W. (1992) Pharmacological effects of remacemide and MK-801 on memory and hippocampal CA1 damage in the rat four-vessel occlusion (4-VO) model of global ischemia, in The Role of Neurotransmitters in Brain Injury (Globus M. and Dietrich W. D., eds), pp. 83-92. Plenum Press, New York.
29. Palmer G. C., Murray R. J., Wilson T. C. M., Eisman M. S., Ray R. K., Griffith R. C., Napier J. J., Fedorchuk M., Stagnitto M. L., and Garske G. E. (1992) Biological profile of the metabolites of the anticonvulsant remacemide. Epilepsy Res 12, 9-20.
30. Palmer G. C., Clark B., and Hutchison J. B. (1993) Antiepileptic and neuroprotective potential of remacemide hydrochloride. Drugs Future 18, 1021-1042.
31. Rogawski M. A. (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325-331.
32. Simon R. P., Swan J. H., Griffiths T., and Meldrum B. S. (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226, 850-852.
33. Tymianski M., Charlton M. P., Carlen P. L., and Tator C. H. (1993) Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13, 2085-2104.
34. Wamil A. W., Cheung H., Harris E. W., and McLean M. J. (1995) Remacemide HCl and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture. Epilepsy Res. (in press).